Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK pathway-driven cancers. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition, FAK inhibition and KRAS G12D inhibition.
Pursuing unexplored pathways demands that we’re purposeful in everything we do. And it’s an endeavor that’s only possible with an experienced team of employees and partners dedicated to a singular purpose: changing and improving the way cancer is treated by delivering novel therapies that address areas of high unmet need in RAS/MAPK pathway-driven cancers. At Verastem Oncology, it takes our diversity of backgrounds, expertise, perspectives, and skills to find the answers that patients need, but don’t have—yet. To join our team or for more information, please visit www.verastem.com.
X/Twitter: @VerastemOncolog
Company Details
- Employees
- 128
- Founded
- -
- Address
- 117 Kendrick Street,
- Phone
- 1-781-292-4200
- in****@****tem.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- verastem.com
- HQ
- Needham, Massachusetts
Verastem Oncology Questions
Verastem Oncology's helpline number is 1-781-292-4200
Verastem Oncology's website is verastem.com
Verastem Oncology's LinkedIn profile is https://www.linkedin.com/company/verastemoncology
Verastem Oncology has
128 employees.
View email and phone details for 128
employees at Verastem Oncology.
Verastem Oncology's industry is
Biotechnology Research
Verastem Oncology's top competitors are
Nuvation Bio,
Vertex Pharmaceuticals,
Viridian Therapeutics, Inc.,
Capricor Therapeutics, Inc.,
Clovis Oncology,
Aveo Oncology,
Travere Therapeutics,
Kura Oncology, Inc.,
Dava Oncology,
Karyopharm Therapeutics Inc..
Verastem Oncology's support email address is info@verastem.com
Verastem Oncology's categories are Biotechnology Research
Verastem Oncology's founding year is 2010
